The development of growth hormone-releasing hormone analogs: Therapeutic advances in cancer, regenerative medicine, and metabolic disorders.
Quick Facts
What This Study Found
GHRH agonists promote tissue regeneration, improve heart function, and help islet survival in diabetes models. GHRH antagonists show antitumor activity against lung, prostate, breast, and GI cancers with minimal toxicity in preclinical studies.
Key Numbers
GHRH antagonist series MIA and AVR demonstrated antitumor activity in preclinical models of lung, prostate, breast, and gastrointestinal cancers.
How They Did This
Narrative review of preclinical and early clinical literature on GHRH agonists and antagonists across oncology, regenerative medicine, and metabolic disorders.
Why This Research Matters
GHRH analogs may have therapeutic uses far beyond growth hormone regulation, spanning cancer, regenerative medicine, inflammation, and neurodegeneration.
What This Study Doesn't Tell Us
Review based mostly on preclinical data. Few human clinical trials. Long-term safety of GHRH analogs in these new indications is unknown.
Trust & Context
- Original Title:
- The development of growth hormone-releasing hormone analogs: Therapeutic advances in cancer, regenerative medicine, and metabolic disorders.
- Published In:
- Reviews in endocrine & metabolic disorders, 26(3), 385-396 (2025)
- Authors:
- Schally, Andrew V(41), Cai, Renzhi(12), Zhang, Xianyang(5), Sha, Wei, Wangpaichitr, Medhi
- Database ID:
- RPEP-13450
Evidence Hierarchy
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-13450APA
Schally, Andrew V; Cai, Renzhi; Zhang, Xianyang; Sha, Wei; Wangpaichitr, Medhi. (2025). The development of growth hormone-releasing hormone analogs: Therapeutic advances in cancer, regenerative medicine, and metabolic disorders.. Reviews in endocrine & metabolic disorders, 26(3), 385-396. https://doi.org/10.1007/s11154-024-09929-2
MLA
Schally, Andrew V, et al. "The development of growth hormone-releasing hormone analogs: Therapeutic advances in cancer, regenerative medicine, and metabolic disorders.." Reviews in endocrine & metabolic disorders, 2025. https://doi.org/10.1007/s11154-024-09929-2
RethinkPeptides
RethinkPeptides Research Database. "The development of growth hormone-releasing hormone analogs:..." RPEP-13450. Retrieved from https://rethinkpeptides.com/research/schally-2025-the-development-of-growth
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.